Tumor necrosis factor-α and tumor necrosis factor receptors in the failing human heart

Circulation

Volumn 93, Issue 4, 1996, Pages 704-711

  Torre Amione, Guillermo ^c   Kapadia, Samir ^c   Lee, Joseph ^c   Durand, Jean Bernard ^c   Bies, Roger D ^a   Young, James B ^c   Mann, Douglas L ^b  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

cells; heart failure; receptors; tumor necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; FEMALE; HEART DILATATION; HEART FAILURE; HUMAN; HUMAN TISSUE; INOTROPISM; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0029670957     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.93.4.704     Document Type: Article

References (48)

1. Suffredini AF, Fromm RE, Parker MM, Brenner M, Kovacs JA, Wesley RA, Parrillo JE. The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med. 1989;321: 280-287.
2. Hegewisch S, Weh HJ, Hossfeld DK. TNF-induced cardiomyopathy. Lancet. 1990;2:294-295.
3. Millar AB, Singer M, Meager A, Foley NM, Johnson NM, Rook GA. Tumor necrosis factor in bronchopulmonary secretions of patients with adult respiratory distress syndrome. Lancet. 1989;2: 712-713.
4. Levine B, Kalman J, Mayer L, Fillit HM, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med. 1990;223:236-241.
5. McMurray J, Abdullah I, Dargie HJ, Shapiro D. Increased concentrations of tumour necrosis factor in 'cachectic' patients with severe chronic heart failure. Br Heart J. 1991;66:356-358.
6. Matsumori A, Yamada T, Suzuki H, Matoba Y, Sasayama S. Increased circulating cytokines in patients with myocarditis and cardiomyopathy. Br Heart J. 1994;72:561-566.
7. Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK. Tumour necrosis factor-alpha in severe congestive cardiac failure. Br Heart J. 1993;70:141-143.
8. Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH. Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide-dependent vasodilation in the forearm circulation. Circulation. 1994;90:12-16.
9. Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science. 1992;257:387-389.
10. Yokoyama T, Vaca L, Rossen RD, Durante W, Hazarika P, Mann DL. Cellular basis for the negative inotropic effects of tumor necrosis factor-alpha in the adult mammalian heart. J Clin Invest. 1993;92:2303-2312.
11. Gulick TS, Chung MK, Pieper SJ, Lange LG, Schreiner GF. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte β-adrenergic responsiveness. Proc Natl Acad Sci USA. 1989;86: 6753-6757.
12. Mann DL, Young JB. Basic mechanisms in congestive heart failure: recognizing the role of proinflammatory cytokines. Chest. 1994;105: 897-904.
13. Chung MK, Gulick TS, Rotondo RE, Schreiner GF, Lange LG. Mechanism of action of cytokine inhibition of β-adrenergic agonist stimulation of cyclic AMP in rat cardiac myocytes: impairment of signal transduction. Circ Res. 1990;67:753-763.
14. Gulick TS, Chung MK, Pieper SJ, Schreiner GF, Lange LG. Immune cytokine inhibition of beta-adrenergic agonist stimulated cyclic AMP generation in cardiac myocytes. Biochem Biophys Res Commun. 1988;150:1-9.
15. Torre-Amione G, Kapadia S, Lee J, Bies RD, Lebovitz R, Mann DL. Expression and functional significance of tumor necrosis factor receptors in human myocardium. Circulation. 1995,92:1487-1493.
16. Aggarwal BB, Graff K, Samal B, Higuchi M, Liao WSL. Regulation of two forms of the TNF receptors by phorbol ester and dibutyryl cyclic adenosine 3′,5′-monophosphate in human histiocytic lymphoma cell line U-937. Lymphokine Cytokine Res. 1993;12: 149-158.
17. Pocsik E, Higuchi M, Aggarwal BB. Down-modulation of cell surface expression of p80 for tumor necrosis factor receptor by human immunodeficiency virus-1 tat gene. Lymphokine Cytokine Res. 1992;11:317-325.
18. Cadranel J, Philippe C, Philippe B, Milleron B, Fouqueray B, Mayaud C, Baud L. Increased expression and occupancy of receptors for tumour necrosis factor on blood monocytes from tuberculosis patients. Clin Exp Immunol. 1993;94:51-56.
19. Kapadia S, Lee JR, Torre-Amione G, Birdsall HH, Ma TS, Mann DL. Tumor necrosis factor gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest. 1995;96:1042-1052.
20. Young JB, Leon CA, Weilbacher DA. Endomyocardial biopsy in critically ill patients: the procedure and diagnostic and prognostic potential. In: Majid P, Kirby RR, Taylor RW, eds. Problems in Critical Care: Advances in Interventional Cardiology. Philadelphia, Pa: JB Lippincott Co; 1988:433-443.
21. Cannon JG, Nerad JL, Poutsiaka DD, Dinarello CA. Measuring circulating cytokines. J Appl Physiol. 1993;75:1897-1902.
22. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning: A Laboratory Approach. Cold Spring Harbor, NY: Cold Spring Harbor Press; 1989.
23. Stauber GB, Aiyer RA, Aggarwal BB. Human tumor necrosis factor-α receptor: purification by immunoaffinity chromatography and initial characterization. J Biol Chem. 1988;263:19098-19104.
24. Friedman G, Gallily R, Chajek-Shaul T, Stein O, Shiloni E, Etienne J, Stein Y. Lipoprotein lipase in heart cell cultures is suppressed by lipopolysaccharide: an effect mediated by production of tumor necrosis factor. Biochim Biophys Acta. 1988;960:220-228.
25. Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B. The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest. 1992;90:693-698.
26. Giroir BP, Horton JW, White JD, McIntyre KL, Lin CQ. Inhibition of tumor necrosis factor prevents myocardial dysfunction during burn shock. Am J Physiol. 1994;267:H118-H124.
27. Pizarro TT, Malinowska K, Kovacs EJ, Clancy J, Robinson JA, Piccinini LA. Induction of TNF-alpha and TNF-beta gene expression in rat cardiac transplants during allograft rejection. Transplantation. 1993;56:399-404.
28. Kapadia S, Torre-Amione G, Mann DL. Plasma cytokine and endotoxin levels in patients with sepsis syndrome. Ann Intern Med. 1994;121:149. Letter.
29. Seckinger PL, Isaaz S, Dayer JM. A human inhibitor of tumor necrosis factor α. J Exp Med. 1988;167:1511-1516.
30. Peetre C, Thysell H, Grubb A, Olsson I. A tumor necrosis factor binding protein is present in human biological fluids. Exp Hematol. 1988;41:414-419.
31. Engelmann H, Aderka M, Rubenstein M, Rotman D, Wallach D. A tumor necrosis factor-binding protein purified to homogeneity from human urine protects cells from tumor necrosis factor toxicity. J Biol Chem. 1989;264:11974-11980.
32. Wiedermann CJ, Beimpold H, Herold M, Knapp E, Braunsteiner H. Increased levels of serum neopterin and decreased production of neutrophil superoxide anions in chronic heart failure with elevated levels of tumor necrosis factor-alpha. J Am Coll Cardiol. 1993;22:1897-1901.
33. Pennica D, Lam VT, Mize NK, Weber RF, Lewis M, Fendly BM, Lipari MT, Goeddel DV. Biochemical properties of the 75-kDa tumor necrosis factor receptor. J Biol Chem. 1992;267:21172-21178.
34. Brakebusch C, Nophar Y, Kemper O, Engelmann H, Wallach D. Cytoplasmic truncation of the p55 tumour necrosis factor (TNF) receptor abolishes signalling, but not induced shedding of the receptor. EMBO J. 1992;11:943-950.
35. Aggarwal BB, Totpal K, Pocsik E, Graff K, Liao W, Higuchi M. Role of protein kinases and phosphatases in receptor biosynthesis, shedding and mediation of cellular responses to tumor necrosis factor. In: Fiers WS, Burman WA, eds. Tumor Necrosis Factor: Molecular and Cellular Biology and Clinical Relevance. Basel, Switzerland: Karger; 1993:65-80.
36. Crowe PD, Vanarsdale TL, Goodwin RG, Ware CF. Specific induction of 80-kDa tumor necrosis factor receptor shedding in t- lymphocytes involves the cytoplasmic domain and phosphorylation. J Immunol. 1993;151:6882-6890.
37. Scheurich P, Kobrich G, Pfizenmaier K. Antagonistic control of tumor necrosis factor receptors by protein kinases A and C: enhancement of TNF receptor synthesis by protein kinase A and transmodulation of receptors by protein kinase C. J Exp Med. 1989; 170:947-958.
38. Johnson SE, Baglioni C. Tumor necrosis factor receptors and cytocidal activity are down-regulated by activators of protein kinase C. J Biol Chem. 1988;263:5686-5692.
39. Ding AH, Sanchez E, Srimal S, Nathan CF. Macrophages rapidly internalize their tumor necrosis factor receptors in response to bacterial lipopolysaccharide. J Biol Chem. 1989;264:3924-3929.
40. Aggarwal BB, Eessalu TE. Effect of phorbol esters on down-regulation and redistribution of cell surface receptors for tumor necrosis factor-α. J Biol Chem. 1987;262:16450-16455.
41. 25I-labeled tumor necrosis factor: specific binding, affinity labeling, and relationship to sensitivity. Proc Natl Acad Sci U S A. 1985;82: 5756-5760.
42. Michishita M, Yoshida Y, Uchino H, Kazuhiro N. Induction of tumor necrosis factor-α and its receptors during differentiation in myeloid leukemic cells along the monocyte pathway. J Biol Chem. 1990;265:8751-8759.
43. Scheurich P, Ucer U, Kronke M, Pfizenmaier K. Quantification and characterization of high-affinity membrane receptors for tumor necrosis factor on human leukemic cell lines. Int J Cancer. 1994;38: 127-133.
44. Peetre C, Gulberg U, Nilsson E, Olsson I. Effects of recombinant tumor necrosis factor on proliferation and differentiation of leukemic and normal hemopoietic cells in vitro: relationship to cell surface receptor. J Clin Invest. 1986;78:1694-1700.
45. Munker R, DiPersio J, Koeffler HP. Tumor necrosis factor: receptors on hematopoietic cells. Blood. 1987;70:1730-1734.
46. Rubin BY, Anderson SL, Sullivan SA, Williamson BD, Carswell EA, Old LJ. Nonhematopoietic cells selected for resistance to tumor necrosis factor produce tumor necrosis factor. J Exp Med. 1986;164:1350-1355.
47. Packer M. The search for the ideal positive inotropic agent. N Engl J Med. 1993;329:201-202.
48. Kapadia S, Torre-Amione G, Yokoyama T, Mann DL. Soluble tumor necrosis factor binding proteins modulate the negative inotropic effects of TNF-α in vitro. Am J Physiol. 1995;37: H517-H525.